SCHEMBL3408692

SCHEMBL3408692

O=C(O)N1C(=O)COC[C@H]1CCCCOCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 3/20 0.39
UGCG Q16739 3/20 0.39
GBA2 Q9HCG7 3/20 0.39
EPHX2 P34913 2/20 0.39
TEAD3 Q99594 2/20 0.38
NAAA Q02083 1/20 0.38
ASAH1 Q13510 1/20 0.36
GRM5 P41594 1/20 0.36
AGTR2 P50052 2/20 0.35
SOAT1 P35610 1/20 0.35
LMNA P02545 1/20 0.35
CTSV O60911 1/20 0.35
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
CTSC P53634 1/20 0.35
CTSF Q9UBX1 1/20 0.35
PDE4D Q08499 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3408814 1.00 GBA1 (0.39) GBA1UGCGGBA2EPHX2TEAD3
SCHEMBL3410203 0.87 L3MBTL1 (0.44) GBA1UGCGGBA2EPHX2NAAA
SCHEMBL13040210 0.87 L3MBTL1 (0.44) GBA1UGCGGBA2EPHX2NAAA
SCHEMBL13040201 0.87 L3MBTL1 (0.44) GBA1UGCGGBA2EPHX2NAAA
SCHEMBL4330112 0.84 LMNA (0.41) GRM5AGTR2LMNACTSLCTSS
SCHEMBL4330114 0.84 LMNA (0.41) GRM5AGTR2LMNACTSLCTSS
SCHEMBL3410206 0.75 NAAA (0.39) GBA1UGCGGBA2EPHX2TEAD3
SCHEMBL3408477 0.74 UGCG (0.36) GBA1UGCGGBA2EPHX2TEAD3
SCHEMBL3411111 0.74 UGCG (0.36) GBA1UGCGGBA2EPHX2TEAD3
SCHEMBL27847181 0.73 EPHX2 (0.42) GBA1UGCGGBA2EPHX2TEAD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101910183-A Preparation method of 4- (substituted phenyl) hexahydropyrido [2,1-C ] [1,4] oxazin-6-one EISAI R&D MAN CO LTD 2010-12-08 CN disclosed
US-20100280243-A1 PROCESS FOR PRODUCTION OF 4- (SUBSTITUTED PHENYL) HEXAHYDROPYRIDO [2,1-C] [1,4] OXAZIN-6-ONE EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-11-04 US disclosed
EP-2226325-A1 PROCESS FOR PRODUCTION OF 4-(SUBSTITUTED PHENYL)HEXAHYDROPYRIDOÝ2,1-C¨Ý1,4¨OXAZIN-6-ONE Eisai R&D Management Co., Ltd. (JP) 2010-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280243-A1 PROCESS FOR PRODUCTION OF 4- (SUBSTITUTED PHENYL) HEXAHYDROPYRIDO [2,1-C] [1,4] OXAZIN-6-ONE PSEN1, APP, BACE1 GBA1 212/4885UGCG 654/4885GBA2 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.